Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519109) titled 'Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Condition:
Postoperative Pain
Intervention:
Drug: SYH9089 injection
Drug: Ropivacaine hydrochloride
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: March 31, 2026
Target Sample Size: 60
To know mo...